Skip to main content

Table 4 Response analysis based on sub-classification of histological features among clear cell tumours

From: High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

Number (%)

“Favourable” N = 123

“Other” N = 21

A N = 83

B N = 33

C N = 7

D N = 3

E N = 3

F N = 5

G N = 10

Papillary <10 %

NO

NO

NO

Alveolar or solid >50 %

NO

NO

NO

NO

Granular <50 %

NO

NO

NO

ORR

42 (50.6)

13 (39.4)

3 (42.9)

2 (66.7)

0 (0)

0 (0)

1 (10.0)

CR

19 (22.9)

7 (21.2)

1 (14.3)

2 (66.7)

0 (0)

0 (0)

0 (0)

PR

23 (27.8)

6 (18.2)

2 (28.6)

0 (0)

0 (0)

0 (0)

1 (10.0)

SD

25 (30.1)

8 (24.2)

2 (28.6)

1 (33.3)

2 (66.7)

2 (40.0)

6 (60.0)

PD

16 (19.3)

12 (36.4)

2 (28.6)

0 (0)

1 (33.3)

3 (60.0)

3 (30.0)

  1. Note: One patient with Type II Papillary carcinoma who achieved CR was excluded from this analysis